132 related articles for article (PubMed ID: 28940490)
1. Carvacryl acetate, a novel semisynthetic monoterpene ester, binds to the TRPA1 receptor and is effective in attenuating irinotecan-induced intestinal mucositis in mice.
Alvarenga EM; Sousa NA; de Araújo S; Júnior JLP; Araújo AR; Iles B; Pacífico DM; Brito GAC; Souza EP; Sousa DP; Medeiros JVR
J Pharm Pharmacol; 2017 Dec; 69(12):1773-1785. PubMed ID: 28940490
[TBL] [Abstract][Full Text] [Related]
2. Carvacrol reduces irinotecan-induced intestinal mucositis through inhibition of inflammation and oxidative damage via TRPA1 receptor activation.
Alvarenga EM; Souza LK; Araújo TS; Nogueira KM; Sousa FB; Araújo AR; Martins CS; Pacífico DM; de C Brito GA; Souza EP; Sousa DP; Medeiros JV
Chem Biol Interact; 2016 Dec; 260():129-140. PubMed ID: 27838229
[TBL] [Abstract][Full Text] [Related]
3. Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation.
Lima-Júnior RC; Figueiredo AA; Freitas HC; Melo ML; Wong DV; Leite CA; Medeiros RP; Marques-Neto RD; Vale ML; Brito GA; Oriá RB; Souza MH; Cunha FQ; Ribeiro RA
Cancer Chemother Pharmacol; 2012 Apr; 69(4):931-42. PubMed ID: 22101361
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis.
Logan RM; Gibson RJ; Bowen JM; Stringer AM; Sonis ST; Keefe DM
Cancer Chemother Pharmacol; 2008 Jun; 62(1):33-41. PubMed ID: 17703303
[TBL] [Abstract][Full Text] [Related]
5. Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide.
Melo ML; Brito GA; Soares RC; Carvalho SB; Silva JV; Soares PM; Vale ML; Souza MH; Cunha FQ; Ribeiro RA
Cancer Chemother Pharmacol; 2008 Apr; 61(5):775-84. PubMed ID: 17624531
[TBL] [Abstract][Full Text] [Related]
6. Carvacryl acetate, a derivative of carvacrol, reduces nociceptive and inflammatory response in mice.
Damasceno SR; Oliveira FR; Carvalho NS; Brito CF; Silva IS; Sousa FB; Silva RO; Sousa DP; Barbosa AL; Freitas RM; Medeiros JV
Life Sci; 2014 Jan; 94(1):58-66. PubMed ID: 24239641
[TBL] [Abstract][Full Text] [Related]
7. The reduction of oxidative stress by nanocomposite Fullerol decreases mucositis severity and reverts leukopenia induced by Irinotecan.
Arifa RDN; Paula TP; Madeira MFM; Lima RL; Garcia ZM; Ÿvila TV; Pinho V; Barcelos LS; Pinheiro MVB; Ladeira LO; Krambrock K; Teixeira MM; Souza DG
Pharmacol Res; 2016 May; 107():102-110. PubMed ID: 26987941
[TBL] [Abstract][Full Text] [Related]
8. Dehydrocostus lactone alleviates irinotecan-induced intestinal mucositis by blocking TLR4/MD2 complex formation.
Sun M; Zhan H; Long X; Alsayed AM; Wang Z; Meng F; Wang G; Mao J; Liao Z; Chen M
Phytomedicine; 2024 Jun; 128():155371. PubMed ID: 38518649
[TBL] [Abstract][Full Text] [Related]
9. Luteolin prevents irinotecan-induced intestinal mucositis in mice through antioxidant and anti-inflammatory properties.
Boeing T; de Souza P; Speca S; Somensi LB; Mariano LNB; Cury BJ; Ferreira Dos Anjos M; Quintão NLM; Dubuqoy L; Desreumax P; da Silva LM; de Andrade SF
Br J Pharmacol; 2020 May; 177(10):2393-2408. PubMed ID: 31976547
[TBL] [Abstract][Full Text] [Related]
10. Serum-derived bovine immunoglobulin/protein isolate in the alleviation of chemotherapy-induced mucositis.
Bateman E; Weaver E; Klein G; Wignall A; Wozniak B; Plews E; Mayo B; White I; Keefe D
Support Care Cancer; 2016 Jan; 24(1):377-385. PubMed ID: 26081596
[TBL] [Abstract][Full Text] [Related]
11. Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile.
Stringer AM; Gibson RJ; Bowen JM; Logan RM; Ashton K; Yeoh AS; Al-Dasooqi N; Keefe DM
Int J Exp Pathol; 2009 Oct; 90(5):489-99. PubMed ID: 19765103
[TBL] [Abstract][Full Text] [Related]
12. The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis.
Nogueira LT; Costa DV; Gomes AS; Martins CS; Silva AM; Coelho-Aguiar JM; Castelucci P; Lima-Júnior RC; Leitão RF; Moura-Neto V; Brito GA
J Neuroinflammation; 2017 Apr; 14(1):79. PubMed ID: 28388962
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat.
Al-Dasooqi N; Gibson RJ; Bowen JM; Logan RM; Stringer AM; Keefe DM
Exp Biol Med (Maywood); 2010 Oct; 235(10):1244-56. PubMed ID: 20682600
[TBL] [Abstract][Full Text] [Related]
14. Preventative effects of selenium-enriched
Qiu Y; Zhang J; Ji R; Zhou Y; Shao L; Chen D; Tan J
Benef Microbes; 2019 May; 10(5):569-577. PubMed ID: 30964326
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of Bu-Zhong-Yi-Qi decoction, the water extract of Chinese traditional herbal medicine, on 5-fluorouracil-induced intestinal mucositis in mice.
Gou H; Gu LY; Shang BZ; Xiong Y; Wang C
Hum Exp Toxicol; 2016 Dec; 35(12):1243-1251. PubMed ID: 26801985
[TBL] [Abstract][Full Text] [Related]
16. Irinotecan-induced mucositis is associated with changes in intestinal mucins.
Stringer AM; Gibson RJ; Logan RM; Bowen JM; Yeoh AS; Laurence J; Keefe DM
Cancer Chemother Pharmacol; 2009 Jun; 64(1):123-32. PubMed ID: 18998135
[TBL] [Abstract][Full Text] [Related]
17. IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice.
Guabiraba R; Besnard AG; Menezes GB; Secher T; Jabir MS; Amaral SS; Braun H; Lima-Junior RC; Ribeiro RA; Cunha FQ; Teixeira MM; Beyaert R; Graham GJ; Liew FY
Mucosal Immunol; 2014 Sep; 7(5):1079-93. PubMed ID: 24424522
[TBL] [Abstract][Full Text] [Related]
18. IL-1Ra selectively protects intestinal crypt epithelial cells, but not tumor cells, from chemotoxicity via p53-mediated upregulation of p21(WAF1) and p27(KIP1.).
Wang X; Zhu S; Qian L; Gao J; Wu M; Gao J; Zhang Y; Chan GL; Yu Y; Han W
Pharmacol Res; 2014 Apr; 82():21-33. PubMed ID: 24681512
[TBL] [Abstract][Full Text] [Related]
19. St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis.
Hu ZP; Yang XX; Chan SY; Xu AL; Duan W; Zhu YZ; Sheu FS; Boelsterli UA; Chan E; Zhang Q; Wang JC; Ee PL; Koh HL; Huang M; Zhou SF
Toxicol Appl Pharmacol; 2006 Oct; 216(2):225-37. PubMed ID: 17015070
[TBL] [Abstract][Full Text] [Related]
20. Dihydrotanshinone attenuates chemotherapy-induced intestinal mucositis and alters fecal microbiota in mice.
Wang L; Wang R; Wei GY; Wang SM; Du GH
Biomed Pharmacother; 2020 Aug; 128():110262. PubMed ID: 32447214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
